Hong Kong SAR

China Tower Corp is set to begin premarketing its Hong Kong IPO next week, after winning listing approval on Thursday for what is expected to be a $10bn deal, according to a source close to trade.

Redsun Properties Group hit the road on Thursday to drum up buy-side demand for its potential HK$2.5bn ($324.2m) Hong Kong IPO.

Hong Kong’s new biotechnology-friendly listing regime attracted IPO filings this week from China-based Innovent Biologics and MicuRx Pharmaceuticals.

Anagh Chaudhry, a member of the Asia ECM syndicate team at Deutsche Bank, has resigned from the firm.

Lossmaking Babytree Group, a Chinese online platform for expecting parents, filed an IPO application in Hong Kong on Thursday.

Health and Happiness International Holdings, previously known as Biostime International Holdings, is seeking an up to $350m loan through Goldman Sachs.

51 Credit Card opened books on Friday for its HK$1.4bn ($173.9m) listing in Hong Kong, with 10 firms in the syndicate.

Beijing-based investment bank Chinese Renaissance has set the ball rolling on its Hong Kong IPO.

The Asian dollar loan market is set for some new competitors. A number of Chinese joint stock commercial banks are seeking approvals to set up branches in Hong Kong, with a view to arranging syndicated deals. What impact will this have? Pan Yue finds out.

Chinese mobile streaming platform Inke hit the road with its Hong Kong IPO this week armed with anchor demand as it seeks up HK$1.5bn ($192.6m).

Banks are obsessed with going digital. Once-staid institutions fall over each other trying to show how disruptive and revolutionary they can be. Local lenders, keen to get in on the act, pitch journalists elaborate stories about their online lending ‘revolution’, which usually amounts to little more than a handful of deals.

Chinese technology unicorn Meituan Dianping is seeking an IPO in Hong Kong that could raise upwards of $4bn.